“Based on the positive outcomes from the protein analysis reported above, Australian Provisional Patent Application No. 2021903024 was filed 20 September 2021 with claims covering applications of ATL1102 in new potential disease settings including diabetic, respiratory and age-related diseases to support the Company’s future commercial and partnering plans for ATL1102.”
- Forums
- ASX - By Stock
- PER
- Ann: New data supports ATL1102s broader clinical potential
Ann: New data supports ATL1102s broader clinical potential, page-3
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
|
|||||
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.12M |
Open | High | Low | Value | Volume |
7.9¢ | 8.0¢ | 7.9¢ | $33.85K | 424.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 76080 | 7.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 10226 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 61080 | 0.078 |
1 | 10000 | 0.077 |
1 | 26000 | 0.076 |
5 | 201800 | 0.075 |
3 | 180866 | 0.074 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 10226 | 1 |
0.081 | 100000 | 1 |
0.083 | 100000 | 1 |
0.084 | 100250 | 1 |
0.085 | 220000 | 2 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
PER (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online